Optimum’s clients continued to gain momentum in March, starting things off on Monday with a substantial financing agreement for Heidelberg Pharma, with HealthCare Royalty for up to $115 million. On Wednesday, Heidelberg followed this with the announcement that it is to present first efficacy data from a Phase 1 clinical trial with ATAC candidate HDP-101. […]
Copenhagen-based research center is awarded up to DKK 1 billion (€134.2 million) from the Novo Nordisk Foundation to support research toward innovative approaches to the diagnosis, prevention, and treatment of cardiometabolic diseases. Read more…
Denmark’s first fully functional generally applicable quantum computer will be available in 2034. This is the objective of the ambitious Novo Nordisk Foundation Quantum Computing Programme that is being launched in collaboration with the University of Copenhagen. Quantum computers will help in developing new medicine and provide new insight into climate change and the green […]
Stem cell medicine is delivering hope for new treatments across many currently untreatable diseases. Stem cells are found throughout the human body and are critical for a healthy life. Recent scientific advances now allow us to identify, isolate and engineer stem cells to create human tissue models, repair injured tissues and in the future grow […]
This year, a staggering 700,000 people will die from infections that cannot be treated by most or all available antibiotics.
